Altered expression of microRNA-16 has been observed in cancer, including malignancies of the breast, colon, brain , lung, lymphatic system, ovaries, pancreas , prostate and stomach. This difference in expression levels can be used distinguish between cancerous and healthy tissues and to determine clinical prognosis.
Differences in microRNA-16 expression have been observed in various cancers, including breast, colon, brain, lung, lymphatic system, ovarian, pancreatic, prostate, and stomach carcinomas. These variations can be used to differentiate between cancerous and healthy tissues and to predict clinical outcomes.